Decreased olfactory bulb volume in idiopathic Parkinson's disease detected by 3.0-Tesla magnetic resonance imaging

Movement Disorders

Volumn 27, Issue 8, 2012, Pages 1019-1025

  Brodoehl, Stefan ^a,b   Klingner, Carsten ^a,b   Volk, Gerd F ^a   Bitter, Thomas ^a   Witte, Otto W ^a,b   Redecker, Christoph ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

MRI; Olfactory bulb; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HUMAN; HYPOSMIA; IDIOPATHIC DISEASE; IN VIVO STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SMELLING DISORDER; STEADY STATE;

AGED; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ODORS; OLFACTORY BULB; OLFACTORY PERCEPTION; PARKINSON DISEASE;

EID: 84863998121     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25087     Document Type: Article

References (49)

1. Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005; 5: 275-283.
2. Korten JJ, Meulstee J. Olfactory disturbances in parkinsonism. Clin Neurol Neurosurg 1980; 82: 113-118.
3. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987; 18: 597-600.
4. Serby M, Corwin J, Conrad P, Rotrosen J. Olfactory dysfunction in Alzheimer's disease and Parkinson's disease. Am J Psychiatry 1985; 142: 781-782.
5. Nordin S, Paulsen JS, Murphy C. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc 1995; 1: 281-290.
6. Jones BP, Moskowitz RH, Butters N. Olfactory discrimination in alcoholic Korsakoff patients. Neuropsychologia 1975; 13: 173-179.
7. Hawkes CH, Shephard BC, Geddes JF, Body GD, Martin JE. Olfactory disorder in motor neuron disease. Exp Neurol 1998; 150: 248-253.
8. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 436-446.
9. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995; 10: 283-287.
10. Yousem DM, Geckle RJ, Bilker WB, Doty RL. Olfactory bulb and tract and temporal lobe volumes. Normative data across decades. Ann N Y Acad Sci 1998; 855: 546-555.
11. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
12. Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003; 110: 517-536.
13. Suzuki M, Takashima T, Kadoya M, Takahashi S, Miyayama S, Taira S. MR imaging of olfactory bulbs and tracts. AJNR Am J Neuroradiol 1989; 10: 955-957.
14. Yousem DM, Geckle RJ, Bilker WB, McKeown DA, Doty RL. Posttraumatic olfactory dysfunction: MR and clinical evaluation. AJNR Am J Neuroradiol 1996; 17: 1171-1179.
15. Mueller A, Rodewald A, Reden J, Gerber J, von Kummer R, Hummel T. Reduced olfactory bulb volume in post-traumatic and post-infectious olfactory dysfunction. Neuroreport 2005; 16: 475-478.
16. Rombaux P, Potier H, Markessis E, Duprez T, Hummel T. Olfactory bulb volume and depth of olfactory sulcus in patients with idiopathic olfactory loss. Eur Arch Otorhinolaryngol 2010; 267: 1551-1556.
17. Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry 2003; 60: 1193-1200.
18. Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE, Gur RE. Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry 2000; 157: 828-830.
19. Thomann PA, Dos Santos V, Seidl U, Toro P, Essig M, Schroder J. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2009; 17: 213-221.
20. Thomann PA, Dos Santos V, Toro P, Schönknecht P, Essig M, Schröder J. Reduced olfactory bulb and tract volume in early Alzheimer's disease-a MRI study. Neurobiol Aging 2009; 30: 838-841.
21. Negoias S, Croy I, Gerber J, et al. Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience 2010; 169: 415-421.
22. Gudziol V, Buschhüter D, Abolmaali N, Gerber J, Rombaux P, Hummel T. Increasing olfactory bulb volume due to treatment of chronic rhinosinusitis-a longitudinal study. Brain 2009; 132: 3096-3101.
23. Wang J, You H, Liu JF, Ni DF, Zhang ZX, Guan J. Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am J Neuroradiol 2011; 32: 677-681.
24. Hummel T, Witt M, Reichmann H, Welge-Luessen A, Haehner A. Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson's disease. J Neurol Sci 2010; 289: 119-122.
25. Mueller A, Abolmaali ND, Hakimi AR, et al. Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study. J Neural Transm 2005; 112: 1363-1370.
26. Scherfler C, Schocke MF, Seppi K, et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006; 129: 538-542.
27. Tinaz S, Courtney MG, Stern CE. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011; 26: 436-441.
28. Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ. MRI and cognitive impairment in Parkinson's disease. Mov Disord 2009; 24( Suppl 2): S748-S753.
29. Wattendorf E, Welge-Lüssen A, Fiedler K, et al. Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 2009; 29: 15410-15413.
30. Bitter T, Gudziol H, Burmeister HP, Mentzel HJ, Guntinas-Lichius O, Gaser C. Anosmia leads to a loss of gray matter in cortical brain areas. Chem Senses 2010; 35: 407-415.
31. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. "Sniffin' sticks": olfactory performance assessed by the combined testing of odor identification, odor discrimination, and olfactory threshold. Chem Senses 1997; 22: 39-52.
32. Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3, 000 subjects. Eur Arch Otorhinolaryngol 2007; 264: 237-243.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
34. Kasten M, Bruggemann N, Schmidt A, Klein C. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2010; 75: 478; author reply, 478-479.
35. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73: 1738-1745.
36. Casselman JW, Kuhweide R, Deimling M, Ampe W, Dehaene I, Meeus L. Constructive interference in steady state-3DFT MR imaging of the inner ear and cerebellopontine angle. AJNR Am J Neuroradiol 1993; 14: 47-57.
37. Abolmaali ND, Hietschold V, Vogl TJ, Huttenbrink KB, Hummel T. MR evaluation in patients with isolated anosmia since birth or early childhood. AJNR Am J Neuroradiol 2002; 23: 157-164.
38. McAuliffe MJ, Lalonde FM, McGarry D, Gandler W, Csaky K, Trus BL. Medical Image Processing, Analysis & Visualization in Clinical Research. Los Alamitos, CA: IEEE Computer Society; 2001.
39. Abolmaali N, Gudziol V, Hummel T. Pathology of the olfactory nerve. Neuroimaging Clin N Am 2008; 18: 233-242, preceding x.
40. Yousem DM, Geckle RJ, Doty RL, Bilker WB. Reproducibility and reliability of volumetric measurements of olfactory eloquent structures. Acad Radiol 1997; 4: 264-269.
41. Buschhüter D, Smitka M, Puschmann S, et al. Correlation between olfactory bulb volume and olfactory function. Neuroimage 2008; 42: 498-502.
42. Larsson M, Semb H, Winblad B, Amberla K, Wahlund LO, Backman L. Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support. Neuropsychology 1999; 13: 47-53.
43. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998; 55: 84-90.
44. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging 1990; 11: 465-469.
45. Nieuwenhuys R, Voogd J, van Huijzen C. The Human Central Nervous System. Berlin: Springer-Verlag; 1998.
46. Winner B, Kohl Z, Gage FH. Neurodegenerative disease and adult neurogenesis. Eur J Neurosci 2011; 33: 1139-1151.
47. Thompson PM, Hayashi KM, de Zubicaray G, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994-1005.
48. Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 1993; 43: 962-965.
49. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1749-1752.